BIOA B — BioArctic AB Income Statement
0.000.00%
Last trade - 00:00
- SEK20.70bn
- SEK20.71bn
- SEK616.00m
2019 December 31st | 2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 282 | 62.3 | 23.1 | 228 | 616 |
Cost of Revenue | |||||
Gross Profit | 251 | 39 | -1.71 | 195 | 565 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 169 | 147 | 163 | 246 | 363 |
Operating Profit | 113 | -85 | -140 | -17.3 | 253 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 113 | -86.7 | -141 | -11.2 | 276 |
Provision for Income Taxes | |||||
Net Income After Taxes | 88.5 | -68.5 | -120 | -11.2 | 229 |
Net Income Before Extraordinary Items | |||||
Net Income | 88.5 | -68.5 | -120 | -11.2 | 229 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 88.5 | -68.5 | -120 | -11.2 | 229 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1 | -0.778 | -1.36 | -0.13 | 2.59 |
Dividends per Share |